Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer

Deregulation and activation of the phosphoinositide 3-kinase (PI3K)/Akt/mammalian (or mechanistic) target of rapamycin (mTOR) pathway have a major role in proliferation and cell survival in breast cancer. However, as single agents, mTOR inhibitors have had modest antitumor efficacy. In this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, S-U, Sangai, T, Akcakanat, A, Chen, H, Wei, C, Meric-Bernstam, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668884/
https://www.ncbi.nlm.nih.gov/pubmed/28991258
http://dx.doi.org/10.1038/oncsis.2017.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668884/
https://www.ncbi.nlm.nih.gov/pubmed/28991258
http://dx.doi.org/10.1038/oncsis.2017.86

Ejemplares similares